173 related articles for article (PubMed ID: 22985631)
1. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
[TBL] [Abstract][Full Text] [Related]
2. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
4. STAT3 induces anti-hepatitis C viral activity in liver cells.
Zhu H; Shang X; Terada N; Liu C
Biochem Biophys Res Commun; 2004 Nov; 324(2):518-28. PubMed ID: 15474458
[TBL] [Abstract][Full Text] [Related]
5. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
[TBL] [Abstract][Full Text] [Related]
6. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
[TBL] [Abstract][Full Text] [Related]
7. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
[TBL] [Abstract][Full Text] [Related]
8. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
[TBL] [Abstract][Full Text] [Related]
11. Involvement of ERK pathway in interferon alpha-mediated antiviral activity against hepatitis C virus.
Zhao LJ; Wang W; Wang WB; Ren H; Qi ZT
Cytokine; 2015 Mar; 72(1):17-24. PubMed ID: 25544181
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
[TBL] [Abstract][Full Text] [Related]
13. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway.
Liu WL; Yang HC; Su WC; Wang CC; Chen HL; Wang HY; Huang WH; Chen DS; Lai MY
PLoS One; 2012; 7(9):e43824. PubMed ID: 22962590
[TBL] [Abstract][Full Text] [Related]
14. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
[TBL] [Abstract][Full Text] [Related]
15. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
[TBL] [Abstract][Full Text] [Related]
16. Conventional protein kinase C inhibition prevents alpha interferon-mediated hepatitis C virus replicon clearance by impairing STAT activation.
Fimia GM; Evangelisti C; Alonzi T; Romani M; Fratini F; Paonessa G; Ippolito G; Tripodi M; Piacentini M
J Virol; 2004 Dec; 78(23):12809-16. PubMed ID: 15542633
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
[TBL] [Abstract][Full Text] [Related]
19. Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha.
Naka K; Ikeda M; Abe K; Dansako H; Kato N
Biochem Biophys Res Commun; 2005 May; 330(3):871-9. PubMed ID: 15809077
[TBL] [Abstract][Full Text] [Related]
20. Interferon alpha and ribavirin collaboratively regulate p38 mitogen-activated protein kinase signaling in hepatoma cells.
He SF; Wang W; Ren H; Zhao LJ; Qi ZT
Cytokine; 2013 Mar; 61(3):801-7. PubMed ID: 23410505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
